We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues New Draft Guidances for Generic Trials
The FDA on Friday published 26 new product-specific draft guidances for generic drug trials and 17 revisions, saying it hopes to broaden access and help cheaper drugs get to market more quickly — including opioids formulated to deter abuse.